Trading window closed for results and briefly reopened for rights allotment

Compliance View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹785.90

prior close

₹785.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-2.8%+3.3% vs market

Pharmaceuticals peers, median of 170sector-1.6%+2.1% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Smallcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

-0.1

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5-2.8+3.3-1.6+2.1

Next day

+0.9-1.7+2.6-0.5+1.4

+1.5+0.5+1.1+1.5-0.0

+0.8pendingpending+2.5-1.7

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The trading window for Natco Pharma's directors, designated persons, relatives and other connected persons was closed from October 1, 2026 until 48 hours after the company declares unaudited results for the quarter ended September 30, 2026. As the rights issue allotment is in progress, the window will be open from October 23 through October 28, 2026 so allotted rights shares can be credited to eligible allottees' demat accounts.

Likely market impact

Insider trading is restricted around results and rights allotment. The October 23-28 opening allows share credits while limiting insider dealing.